Newswire (Published: Tuesday, February 26, 2019, 3:39:00 PM CST, Received: Tuesday, February 26, 2019, 3:39:37 PM CST)
Word Count: 558
The cancer which spread to Petersen's bladder and bones was discovered during a routine doctor visit. "They did an annual chemistry test and the PSA level instead of being below four which is normal it was nine," said Petersen. Petersen's prostate-specific antigen or PSA rose to an alarming 46 within two months. "The way it was rising, I wasn't sure I would be around."
Taken aback by the devastating news, Petersen relied on his faith and his family to move forward. "My wife and I are very close. She is my rock. We decided we would face this together and of course, pray. That's been my comfort."
After completing chemotherapy treatments Petersen became the first patient to enroll in a prostate cancer antigen vaccine trial. "He's been doing great so far," said Dr.
Patients like Petersen with very low PSA levels are given several combinations of immunotherapies. "What we're doing is combining this vaccine with a few other immunotherapies as well to try to really jump-start the immune system,"
Petersen says he has noticed a dramatic change in the way he feels. "I can tell by my own symptoms that I'm doing much better feeling much better. I feel ten years younger than I did before."
In a few weeks, Petersen will be given a personalized vaccine custom made from his tumor.
"We hope this is really going to significantly impact metastatic prostate cancer," said
Now, Wash U scientists are working to find a cure for prostate cancer. Because of the promising results with the new immunotherapies and the combinations being used,
That's inspiring news for Petersen, a prostate cancer patient who now has new hope. "If it does not bring me to a cure, I know it's going to enhance the future of men with prostate cancer."
(c)2019 KTVI-TV, St. Louis
Visit KTVI-TV, St. Louis at www.fox2now.com
Distributed by Tribune Content Agency, LLC.